12:00 AM
Jan 09, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BL-1040: Phase II started

Ikaria began the double-blind, placebo-controlled, international Phase II PRESERVATION I trial to evaluate 4 mL intracoronary IK-5001 in about 300 patients who had successful percutaneous coronary intervention (PCI) following acute ST-segment elevation myocardial infarction (STEMI)....

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >